Article Information
History
- June 22, 2020.
Article Versions
- Version 1 (April 20, 2020 - 05:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Daniel B. Larremore1,2,*,
- Bailey K. Fosdick3,
- Kate M. Bubar4,5,
- Sam Zhang4,
- Stephen M. Kissler6,
- C. Jessica E. Metcalf7,
- Caroline O. Buckee8,9 and
- Yonatan H. Grad6,*
- 1Department of Computer Science, University of Colorado Boulder, Boulder, CO, 80309, USA
- 2BioFrontiers Institute, University of Colorado Boulder, Boulder, CO, 80303, USA
- 3Department of Statistics, Colorado State University, Fort Collins, CO, 80523, USA
- 4Department of Applied Mathematics, University of Colorado Boulder, Boulder, CO, 80303, USA
- 5IQ Biology Program, University of Colorado Boulder, Boulder, CO, 80309, USA
- 6Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
- 7Department of Ecology and Evolutionary Biology and the Woodrow Wilson School, Princeton University, Princeton, NJ, 08540, USA
- 8Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
- 9Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA
- ↵*To whom correspondence should be addressed; E-mail: daniel.larremore{at}colorado.edu and ygrad{at}hsph.harvard.edu.
Posted June 22, 2020.
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
